Ubs Group Ag Rx Sight, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Rx Sight, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 24,161 shares of RXST stock, worth $860,131. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,161

Previous 18,365 31.56%

Holding current value

$860,131

Previous $1.11 Million 8.05%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.78 - $57.04 $236,360 - $330,603	5,796 Added 31.56%	24,161 $1.19 Million
Q2 2024 Aug 13, 2024	SELL	$50.42 - $64.29 $685,661 - $874,279	-13,599 Reduced 42.54%	18,365 $1.11 Million
Q1 2024 May 13, 2024	SELL	$35.51 - $57.92 $95,628 - $155,978	-2,693 Reduced 7.77%	31,964 $1.65 Million
Q4 2023 Feb 09, 2024	BUY	$20.91 - $40.9 $343,634 - $672,150	16,434 Added 90.18%	34,657 $1.4 Million
Q3 2023 Nov 09, 2023	SELL	$27.05 - $33.37 $19,719 - $24,326	-729 Reduced 3.85%	18,223 $508,000
Q2 2023 Aug 11, 2023	BUY	$16.37 - $28.9 $184,997 - $326,598	11,301 Added 147.71%	18,952 $545,000
Q1 2023 May 12, 2023	BUY	$12.58 - $16.68 $28,468 - $37,746	2,263 Added 42.0%	7,651 $127,000
Q4 2022 Feb 08, 2023	BUY	$9.93 - $14.2 $43,086 - $61,613	4,339 Added 413.63%	5,388 $68,000
Q3 2022 Nov 10, 2022	BUY	$11.19 - $15.85 $11,738 - $16,626	1,049 New	1,049 $13,000
Q2 2022 Aug 10, 2022	SELL	$10.61 - $16.66 $41,251 - $64,774	-3,888 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.97 - $14.03 $2,529 - $3,956	282 Added 7.82%	3,888 $48,000
Q4 2021 Feb 14, 2022	BUY	$9.52 - $13.81 $34,329 - $49,798	3,606 New	3,606 $40,000

Others Institutions Holding RXST

# of Institutions

224

Shares Held

32.3M

Call Options Held

394K

Put Options Held

32K

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $984M
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account